Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381509 · ClinicalTrials.gov registry record
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 1,428
- Enrollment target
NCT02381509 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 1,428 participants.
The verdict
NCT02381509 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 1,428 participants
- Enrollment target
Study Summary
PRESERVE is a multi-center, prospective, open-label, non-randomized investigation of commercially available IVC filters from 6 manufacturers placed in subjects for the prevention of pulmonary embolism (PE). This study will enroll up to 1,800 IVC filter subjects (with a maximum of 300 subjects per IVC filter brand) at up to 60 sites in the US. The primary objective of this investigational device exemption (IDE) clinical investigation is to evaluate the safety and effectiveness of the commercially available IVC filters (retrievable and permanent) in subjects with clinical need for mechanical prophylaxis of PE with an IVC filter.
Interventions
- DEVICE IVC Filter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,428 participants |
| Start Date | 2015-10 |
| Est. Completion | 2021-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02381509
The ClinicalTrials.gov registry entry for NCT02381509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IVC Filter is the first listed.
NCT02381509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02381509 about?
NCT02381509 is a clinical study titled "Predicting the Safety and Effectiveness of Inferior Vena Cava Filters". PRESERVE is a multi-center, prospective, open-label, non-randomized investigation of commercially available IVC filters from 6 manufacturers placed in subjects for the prevention of pulmonary embolism (PE). This study will enroll up to 1,800 IVC filter subjects (with a maximum of 300 subjects per IV...
What is the current status of trial NCT02381509?
This trial is currently completed. The enrollment target is 1,428 participants. The study started on 2015-10. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT02381509?
The interventions under investigation include: IVC Filter (DEVICE).
Who is sponsoring clinical trial NCT02381509?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.